Global Peri-implantitis Market Size Study, by Method Type, by End-User, and Regional Forecasts 2022-2032

PUBLISHED: February 25, 2025

PAGES: 285 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The global peri-implantitis market is anticipated to witness remarkable growth, reaching USD 2.08 billion by 2032, from its 2023 valuation of USD 0.95 billion, expanding at a robust CAGR of 9.1% over the forecast period. This expansion reflects the increasing prevalence of peri-implantitis due to the rising popularity of dental implants and the aging global population.

Peri-implantitis, characterized by infection and inflammation around dental implants, has emerged as a growing concern as implants become a mainstream solution for tooth replacement. Advanced treatment modalities, including innovative surgical techniques and minimally invasive non-surgical approaches, have positioned this market for accelerated growth. Notably, surgical procedures like bone regeneration and implantoplasty are gaining traction for their efficacy in reversing severe peri-implant conditions.

End-user segmentation highlights how dental clinics dominate the market due to their accessibility and growing adoption of advanced peri-implantitis treatment methods. Hospitals are also key contributors, particularly for complex surgical interventions, while pharmacies play a significant role in providing antibiotics and antiseptics essential for managing peri-implantitis.

Technological advancements in dental care are reshaping the peri-implantitis landscape. Laser-assisted therapies, antimicrobial coatings, and refined surgical methodologies offer effective, patient-centric solutions, significantly improving outcomes. These innovations align with the increasing demand for preventive and corrective dental care, particularly among aging populations and individuals undergoing cosmetic dental procedures.

Major market players included in this report are:

Pfizer Inc.
Cadila Pharmaceuticals
Geistlich Pharma India Pvt. Ltd.
Zimmer Biomet
Institut Straumann AG
Dentsply Sirona
GaronitPharma
Basic Pharma Life Science Pvt Ltd.
Healthy Life Pharma Private Limited
Prachi Pharmaceuticals Private Limited
Nobel Biocare
Neoss Limited
BioHorizons
Keystone Dental
Biolase, Inc.

The detailed segments and sub-segments of the market are explained below:

By Method Type:

Surgical
- Bone Regeneration
- Open Flap Debridement
- Implantoplasty
Non-surgical
- Mechanical Debridement
- Laser Debridement
- Antibiotics
- Others

By End-User:

Dental Clinics
Hospitals
Pharmacies
Others

By Region:

North America: U.S., Canada, Mexico
Europe: UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway
Asia Pacific: Japan, China, India, Australia, South Korea, Thailand
Latin America: Brazil, Argentina
Middle East & Africa: South Africa, Saudi Arabia, UAE, Kuwait

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional-level analysis for each market segment.
Detailed analysis of geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand-side and supply-side analysis of the market.

Chapter 1. Global Peri-implantitis Market Executive Summary

1.1. Global Peri-implantitis Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Method Type
- 1.3.2. By End-User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Peri-implantitis Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Peri-implantitis Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising demand for dental implants
- 3.1.2. Increasing prevalence of peri-implantitis
- 3.1.3. Advancements in dental technologies
3.2. Market Challenges
- 3.2.1. High cost of peri-implantitis treatments
- 3.2.2. Limited awareness in developing regions
3.3. Market Opportunities
- 3.3.1. Emerging markets in Asia Pacific
- 3.3.2. Development of innovative, minimally invasive treatments

Chapter 4. Global Peri-implantitis Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Peri-implantitis Market Size & Forecasts by Method Type 2022-2032

5.1. Segment Dashboard
5.2. Global Peri-implantitis Market: Method Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Surgical
  - 5.2.1.1. Bone Regeneration
  - 5.2.1.2. Open Flap Debridement
  - 5.2.1.3. Implantoplasty
- 5.2.2. Non-Surgical
  - 5.2.2.1. Mechanical Debridement
  - 5.2.2.2. Laser Debridement
  - 5.2.2.3. Antibiotics
  - 5.2.2.4. Others

Chapter 6. Global Peri-implantitis Market Size & Forecasts by End-User 2022-2032

6.1. Segment Dashboard
6.2. Global Peri-implantitis Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Dental Clinics
- 6.2.2. Hospitals
- 6.2.3. Pharmacies
- 6.2.4. Others

Chapter 7. Global Peri-implantitis Market Size & Forecasts by Region 2022-2032

7.1. North America Peri-implantitis Market
- 7.1.1. U.S. Peri-implantitis Market
- 7.1.2. Canada Peri-implantitis Market
- 7.1.3. Mexico Peri-implantitis Market
7.2. Europe Peri-implantitis Market
- 7.2.1. UK Peri-implantitis Market
- 7.2.2. Germany Peri-implantitis Market
- 7.2.3. France Peri-implantitis Market
- 7.2.4. Italy Peri-implantitis Market
- 7.2.5. Spain Peri-implantitis Market
- 7.2.6. Denmark Peri-implantitis Market
- 7.2.7. Sweden Peri-implantitis Market
- 7.2.8. Norway Peri-implantitis Market
- 7.2.9. Rest of Europe Peri-implantitis Market
7.3. Asia Pacific Peri-implantitis Market
- 7.3.1. Japan Peri-implantitis Market
- 7.3.2. China Peri-implantitis Market
- 7.3.3. India Peri-implantitis Market
- 7.3.4. Australia Peri-implantitis Market
- 7.3.5. South Korea Peri-implantitis Market
- 7.3.6. Thailand Peri-implantitis Market
- 7.3.7. Rest of Asia Pacific Peri-implantitis Market
7.4. Latin America Peri-implantitis Market
- 7.4.1. Brazil Peri-implantitis Market
- 7.4.2. Argentina Peri-implantitis Market
- 7.4.3. Rest of Latin America Peri-implantitis Market
7.5. Middle East & Africa (MEA) Peri-implantitis Market
- 7.5.1. Saudi Arabia Peri-implantitis Market
- 7.5.2. South Africa Peri-implantitis Market
- 7.5.3. UAE Peri-implantitis Market
- 7.5.4. Kuwait Peri-implantitis Market
- 7.5.5. Rest of MEA Peri-implantitis Market

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
- 8.1.1. Pfizer Inc.
- 8.1.2. Institut Straumann AG
- 8.1.3. Geistlich Pharma India Pvt. Ltd.
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. Pfizer Inc.
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Market Strategies
- 8.3.2. Institut Straumann AG
- 8.3.3. Geistlich Pharma India Pvt. Ltd.

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes